Details
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) negatively impacts cardiac function, overall health, and quality of life (QOL). The gradual buildup of amyloid fibrils in ATTR-CM results in cardiac remodeling, affects cardiac function, and adversely impacts patients' quality of life. Join HFSA's faculty in this Cardio Town Hall to explore how existing treatments can positively influence these areas and enhance patient outcomes.